IPD chart, page-591

First 591 Last

Share
Profile

Follow
Lies&damnlies

3,085 Posts.

2204

27/06/23

13:19

Post #: 68490853
Share

Originally posted by Lies&damnlies: ↑

Hi Folks

After the todays announcement I couldn't help myself I had to come up with another chart. Compulsive charter? Yes

After the capital raise I swore I wouldn't come back for a long while. I tell Lies.

From the chart you will notice that we have formed a second Rod of Lies (ROL). When the first one broke it headed downwards on the CR news.

Lets see which direction this one breaks. Upwards? Maybe.

Another couple of these announcements would help. But it will be the quarterly reports showing the signs of revenue increases that will be critical. Remember we have hired more staff. Will the revenue increases match the extra costs? Who knows.

How long until that cash burn starts to decline? Who knows.

I'm a chartist, so I can only interpret what I see.

If the break from the ROL upwards and the SP gets to 0.20 then the projections of the FIB's point to the first target area being between 0.22-0.24.
If that happens there will likely be a period of profit taking and a retrace. That's normal in an advancing stock.

Firstly need to get above that first ROL higher than 0.185 and then 0.20 next.

Just the may I deal with the markets so that I am not surprised by what plays out, as always DYOR.

We shall see?

cheers Lies

Expand

Hi Folks

Follow up on my last chart.

Yesterday we broke the second "Rod Of Lies" to the upside. big follow on this morning.

I will update my chart after close of trading today.

Much, much better than breaking it downwards.

Faint glimmer of Hope?

cheers Lies

IPD Price at posting: 18.5¢ Sentiment: Hold Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

CU6

Clarity progresses SECuRE trial with positive safety results

3 stocks with antimony news on Thursday

CHN

Chalice jumps on Putin nickel export ban threat – but then there's bad news

GTR

GTI extends uranium mineralisation at Lo Hema through development drilling

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3